UCSF researchers in collaboration with the Centers for Disease Control’s Tuberculosis Trials Consortium and the AIDS Clinical Trials Group published a landmark study in the New England Journal of Medicine that demonstrated a new four-month treatment regimen for tuberculosis (TB) was safe and as efficacious as the standard six-month therapy. “The new four-month regimen is going to be a preference for...
